Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
Sex differences in myocardial oxygen and glucose metabolism
Authors
Linda R. Peterson
Pablo F. Soto
Pilar Herrero
Kenneth B. Schechtman
Carmen Dence
Robert J. Gropler
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 4/2007
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1016/j.nuclcard.2007.03.001

Other articles of this Issue 4/2007

Journal of Nuclear Cardiology 4/2007 Go to the issue

Original Articles

Assessment of transient left ventricular dilation ratio via 2-day dipyridamole Tc-99m sestamibi nongated myocardial perfusion imaging

Editorial

Transient ischemic dilation ratio: A universal high-risk diagnostic marker in myocardial perfusion imaging

ASNC Presentations

Corridor4DM: The Michigan method for quantitative nuclear cardiology

Editorial Point of View

Recent technologic advances in nuclear cardiology

ASNC Presentations

Quantitation in gated perfusion SPECT imaging: The Cedars-Sinai approach

Nuclear Cardiology Bullet

Dobutamine-induced myocardial infarction with normal coronary arteries during stress SPECT myocardial perfusion imaging

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits